TY - JOUR
T1 - Cancer immunotherapy and heat-shock proteins
T2 - Promises and challenges
AU - Manjili, Masoud H.
AU - Wang, Xiang Yang
AU - MacDonald, Ian J.
AU - Arnouk, Hilal
AU - Yang, Gary Y.
AU - Pritchard, Michele T.
AU - Subjeck, John R.
N1 - Expert Opin Biol Ther. 2004 Mar;4(3):363-73. Review
PY - 2004/3
Y1 - 2004/3
N2 - Recent mechanistic studies on the role of heat-shock proteins (HSPs) to induce innate and adaptive immune responses have resulted in conflicting reports. Whereas some groups reported that HSPs have direct immunological function, others emphasised the endotoxin contamination of HSP preparations and questioned the antigen-specificity of HSP vaccines. The present review will discuss these issues and suggest that HSPs have diverse and distinct immunological functions that could be superimposed on effects resulting from endotoxin contamination or misunderstood by using experimental procedures with inadequate controls. To understand the actual function of HSPs in their interaction with the immune system, methods and procedures need to be optimised and appropriate controls need to be used. These points should also clarify the conflicting findings about HSPs and promote our knowledge about other immuologically important components that may be present in HSP preparations.
AB - Recent mechanistic studies on the role of heat-shock proteins (HSPs) to induce innate and adaptive immune responses have resulted in conflicting reports. Whereas some groups reported that HSPs have direct immunological function, others emphasised the endotoxin contamination of HSP preparations and questioned the antigen-specificity of HSP vaccines. The present review will discuss these issues and suggest that HSPs have diverse and distinct immunological functions that could be superimposed on effects resulting from endotoxin contamination or misunderstood by using experimental procedures with inadequate controls. To understand the actual function of HSPs in their interaction with the immune system, methods and procedures need to be optimised and appropriate controls need to be used. These points should also clarify the conflicting findings about HSPs and promote our knowledge about other immuologically important components that may be present in HSP preparations.
KW - Cancer vaccines
KW - Danger signal
KW - Heat-shock proteins
KW - Immunotherapy
KW - Major histocompatibility complex
KW - Antineoplastic Agents/pharmacology
KW - Animals
KW - Humans
KW - Antigen Presentation/drug effects
KW - Neoplasms/immunology
KW - Heat-Shock Proteins/immunology
UR - http://www.scopus.com/inward/record.url?scp=1542468072&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=1542468072&partnerID=8YFLogxK
UR - https://www.mendeley.com/catalogue/f5b0b52f-3d62-33be-987d-13e9804b6c27/
U2 - 10.1517/14712598.4.3.363
DO - 10.1517/14712598.4.3.363
M3 - Review article
C2 - 15006730
SN - 1471-2598
VL - 4
SP - 363
EP - 373
JO - Expert Opinion on Biological Therapy
JF - Expert Opinion on Biological Therapy
IS - 3
ER -